Shanghai Libang Pharmaceutical Technology

Libang Pharmaceutical is a specialized Chinese pharmaceutical company focused on the development and production of oncology therapeutics and high-potency active pharmaceutical ingredients (APIs). The company is recognized as a major global supplier of taxanes, including paclitaxel and docetaxel, produced through advanced semi-synthetic and extraction processes. Its Shanghai-based subsidiary, Shanghai Libang Pharmaceutical Technology, functions as the group's primary research and development center, focusing on formulation innovation and generic drug development. Libang maintains multiple GMP-certified manufacturing sites and provides contract development and manufacturing services (CDMO) to global pharmaceutical partners. The company's product portfolio extends beyond oncology to include cardiovascular and anti-infective treatments. With a strong emphasis on quality compliance, Libang exports its products to regulated markets including the United States, Europe, and Japan.